Tailoring Gynecologic Cancer Education for Health Care Providers
Information Collection Submitted Under
OMB No. 0920-0800 (generic)
Focus Group Testing to Effectively Plan and Tailor
Cancer Prevention and Control Communication Campaigns
Supporting Statement Part B
March 28, 2014
Technical Monitor:
Katrina Trivers, PhD, MSPH
Division of Cancer Prevention and Control
Phone: 770-488-1086
Fax: 770-488-4639
E-mail: [email protected]
Supported by:
Centers for Disease Control and Prevention
National Center for Chronic Disease Prevention and Health Promotion
Division of Cancer Prevention and Control
4770 Buford Highway, NE, Mailstop F76
Chamblee, GA 30341
TABLE OF CONTENTS
B. Data Collection & Statistical Methods……………………………………………………..
B1. Respondent Universe……………………………………………………………
B2. Procedures for Information Collection………………………………………….
B3. Methods to Maximize Response Rates………………………………………….
B4. Tests of Procedures or Methods to be Undertaken……………………………...
B5. Individuals Consulted on Statistical Aspects and Individuals Collecting and/or
Analyzing Data…………………………………………………………………..
List of Appendices
A. Focus Group Discussion Guide for Group A
B. Focus Group Discussion Guide for Group B
C. Respondent Recruitment Form
B. DATA COLLECTION & STATISTICAL METHODS
Data collection will consist of a focus group methodology. In a focus group, a small group of people engage in a discussion of selected topics of interest typically directed by a moderator who guides the discussion in order to obtain the group’s opinions (Edmunds, 1999; Krueger & Casey, 2000).
B1. Respondent Universe
CDC aims to conduct 2 focus groups. Each focus group will have 20 respondents.
The primary target audience is resident physicians currently enrolled in a primary care residency program at an academic medical institution. Residents will not be screened prior to participation but rather will be considered eligible by virtue of their enrollment in a residency program. The estimated number of participating residents is 36. A secondary audience is supervisors/ mentors/ directors involved with the residency program. The estimated number of participating supervisors is 4. The total number of respondents is 40. These respondents represent a convenience sample of the target audience(s) at a collaborating medical institution.
Qualitative information will be collected to provide insights about respondents’ knowledge, attitudes, beliefs, and behavioral intent regarding the diagnosis and treatment of gynecologic cancers. Focus group findings will be used to inform the development and refinement of educational materials for medical residents. This activity is one of the dissemination strategies for key messages developed for CDC’s Inside Knowledge: Get the Facts about Gynecologic Cancer campaign.
B2. Procedures for Information Collection
CDC plans to conduct 2 focus groups on-site at a collaborating medical center. Each focus group will be comprised of 20 respondents.
Respondents will be recruited via telephone by the data collection contractor, SciMetrika, LLC, using enrollment lists of the residency program of interest at the collaborating academic medical institution and the supervisors affiliated with the program. We will call eligible participants until we reach the target number of participants for each focus group.
Each respondent will sign a consent form (Appendix D) prior to participating in a focus group discussion.
The first focus group will take place prior to the introduction of any specific educational materials and will focus on elucidating existing knowledge gaps, attitudes, beliefs, behavioral intent and current practices regarding gynecologic cancers. The attached focus group guide (Appendix A) will be used to guide the discussion. The information collected will be used by DCPC to appropriately plan for the development of the educational modules on gynecological cancer.
The second focus group will take place approximately 1-3 months after the first focus group (after the receipt of materials) and will ask about continued knowledge gaps, attitudes, beliefs, behavioral intent, current practices regarding gynecologic cancers, appeal, saliency, and likely uptake of the modules. The attached focus group guide (Appendix B) will be used to guide the discussion. Participants in Group A will not necessarily be excluded from Group B, but the two groups will be independent and recruitment for each will be separate.
B3. Methods to Maximize Response Rates
Participants will be recruited from lists of enrolled people in a residency program, our target audience, which offers an abundant supply of people in our target population. That in addition to our incentive should allow for sufficient response rates. An incentive will be offered in the form of refreshments. If that incentive fails to achieve the target number of respondents, we propose to offer a gift card to a local coffee shop.
B4.Tests of Procedures or Methods to be Undertaken
All DCPC communication campaigns are guided by the Health Communication Process (National Cancer Institute, 2002) which involves four stages: (stage 1) planning and strategy development; (stage 2) developing and pretesting concepts, messages, and materials; (stage 3) implementing the program; and (stage 4) assessing effectiveness and making refinements. The Health Communication Process is not linear, but rather is a circular model in which stages are revisited in a continuous loop of planning, development, implementation, and refinement. DCPC campaign staff carefully record all aspects of campaign development, operation, and evaluation. Innovations and improvements are incorporated into subsequent campaign cycles and periodically published in the peer-review literature (Cooper et al., 2011, Cooper et al. 2013). The use of focus group methodology to inform the development and refinement of communication campaigns has been well documented throughout the literature (Bull, et al., 2002; Edmunds, 1999; Krueger, 1994; Krueger & Casey, 2000; Cooper et al., 2011). Thus, the formative and materials-testing methods currently used by DCPC campaigns have been refined in 14 years of campaign operations.
B5. Individuals Consulted on Statistical Aspects and Individuals Collecting and/or Analyzing Data
The following individuals have been consulted on the design of this qualitative information collection:
Jenny Patterson, MPH
SciMetrika, LLC
100 Capitola Dr., Suite 106
Durham, NC 27713
Phone: (919) 354-5238
Yvonne Wasilewski, PhD
SciMetrika, LLC
100 Capitola Dr., Suite 106
Durham, NC 27713
Phone: (919) 354-5223
Cynthia A. Gelb, BSJ
Division of Cancer Prevention and Control
Centers for Disease Control and Prevention
4770 Buford Highway NE, Mailstop F76
Chamblee, GA 30341
Phone: (770) 488-4708
Sherri Stewart, PhD
Division of Cancer Prevention and Control
Centers for Disease Control and Prevention
4770 Buford Highway NE, Mailstop F76
Chamblee, GA 30341
Phone: (770) 488-4616
Nikki Hawkins, PhD
Division of Cancer Prevention and Control
Centers for Disease Control and Prevention
4770 Buford Highway NE, Mailstop F76
Chamblee, GA 30341
Phone: (770) 488-4229
Kate Roland, MPH
Division of Cancer Prevention and Control
Centers for Disease Control and Prevention
4770 Buford Highway NE, Mailstop F76
Chamblee, GA 30341
Phone: 770-488-1089
The following individuals outside of the agency have been consulted on the focus group discussion guides:
Laura-Mae Baldwin, MD
7023 14th Avenue NE
Seattle, WA 98115
Phone: 206-685-4799
Anna-Barbara Moscicki, MD
120 Coronet Avenue
Mill Valley, CA 94941
Phone: 415-476-2814
Beth Y. Karlan, M.D.
Cedars-Sinai Medical Center
David Geffen School of Medicine at UCLA
Phone: 310-423-3302
Joseph S. Green, Ph.D.
Duke Clinical Research Institute
Center for Educational Excellence
300 West Morgan Street, Suite 800
Durham, NC 27701
Phone: 202-557-4670
Stacy Higgins, MD
Emory University School of Medicine
49 Jesse Hill Jr. Drive, SE
Atlanta, GA 30303
Phone: 404-778-1652
Danielle Jones, MD, FACP
Emory University School of Medicine
49 Jesse Hill Jr. Drive, SE
Atlanta, GA 30303
Phone: 404-778-1652
Jenny Patterson, MPH
SciMetrika, LLC
100 Capitola Dr., Suite 106
Durham, NC 27713
Phone: (919) 354-5238
Yvonne Wasilewski, PhD
SciMetrika, LLC
100 Capitola Dr., Suite 106
Durham, NC 27713
Phone: (919) 354-5223
Donna Shaw
SciMetrika, LLC
100 Capitola Dr., Suite 106
Durham, NC 27713
Phone: (919) 354-5260
| File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
| File Title | Supporting Statement for |
| Author | sxw2 |
| File Modified | 0000-00-00 |
| File Created | 2021-01-31 |